An overview of key issues in U.S. health insurance, FDA regulatory inconsistencies, health care costs, anti-vaccine impacts, and emerging digital health policies affecting public health.

The Safe Food Coalition urges urgent regulatory action after a Clostridium botulinum outbreak linked to ByHeart infant formula reveals inspection gaps, stressing need for enhanced safety protocols in infant nutrition products.

Explore Medicare coverage guidelines for Botox focusing on FDA-approved medical uses, prior authorization, medical necessity, and cost factors under Medicare Part B and Advantage plans.

Comprehensive 2026 U.S. legislative and regulatory forecast impacting insurance, healthcare, infrastructure, and technology sectors. Key updates on ACA subsidies, FDA reauthorization, transportation, and trade policies shaping compliance and market strategies.

CMS introduces the ACCESS Model to improve Medicare chronic care with digital health innovation and outcome-based payments starting 2026.

Discover the insurance challenges surrounding FDA-approved vertebral body tethering for scoliosis. Understand insurer denial reasons, clinical outcomes, and impact on patient care.

Great Lakes Cheese recalls shredded cheese nationwide amid FDA warning of metal fragments; affects major brands including Walmart and Aldi. No reported illnesses.

The FDA has reassigned the director of its Office of Nonprescription Drugs to a medical devices leadership role, highlighting a strategic shift toward affordability and regulatory realignment. This change may impact drug approval policies and insurance regulatory compliance.

The FDA appoints Tracy Beth Høeg as the new director of CDER, marking the fifth leadership change this year, impacting drug regulation and insurance sectors.

Georgia man sentenced for $24M Medicare genetic testing kickback scheme; FDA warns on lead in cookware; new guidance limits primate testing in drug development.